I’ve been awarded a Springboard Award from The Academy of Medical Sciences (project SBF009\1016, £125,000, August 2024 to July 2026) for STEROSPRING, characterising an uncharted lanosterol catabolic pathway in non-tuberculous mycobacterial (NTM) species.